Cite

HARVARD Citation

    Muto, M. et al. (2021). Trastuzumab emtansine (T-DM1) and concurrent radiotherapy for treatment of HER2-positive breast cancer: Review of literature. Journal of translational science. 7 (5), p. . [Online]. 
  
Back to record